IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:2562-2568.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-1429

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, X.-H.
Right arrow Articles by Ohno, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, X.-H.
Right arrow Articles by Ohno, S.

Inhibitory Effects of Lutein on Endotoxin-Induced Uveitis in Lewis Rats

Xue-Hai Jin,1 Kazuhiro Ohgami,1 Kenji Shiratori,1 Yukari Suzuki,1 Takeshi Hirano,2 Yoshikazu Koyama,3 Kazuhiko Yoshida,1 Iliyana Ilieva,1 Ken Iseki,2 and Shigeaki Ohno1

1From the Departments of Ophthalmology and Visual Sciences and 3Biochemistry, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and the 2Department of Clinical Pharmaceutics and Therapeutics, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

PURPOSE. Lutein deposits in the macula and lens of human eyes with high concentration and is well known as an eye-protective nutrient for its beneficial effects on eye disease such as age-related macular degeneration and cataract. The purpose of the present study was to investigate the effects of lutein on endotoxin-induced uveitis (EIU) in rats.

METHODS. EIU was induced in male Lewis rats by subcutaneous injection of 200 µg lipopolysaccharide. Lutein or dexamethasone was administered intravenously at 30 minutes before, at the same time as, and at 30 minutes after LPS treatment. The aqueous humor was collected at 24 hours after LPS injection, the number of infiltrating cells, the protein concentration, and the levels of nitric oxide (NO), tumor necrosis factor (TNF)-{alpha}, interleukin (IL)-6, prostaglandin (PG)-E2, monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein (MIP)-2 in the aqueous humor were determined. Immunohistochemical staining with a monoclonal antibody against activated nuclear factor (NF)-{kappa}B was performed to evaluate the effect of lutein on NF-{kappa}B activation in the iris-ciliary body (ICB) of rats. A mouse macrophage cell line (RAW264.7 cells) was stimulated with LPS in the presence or absence of lutein. Expression of inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), and degradation of inhibitor {kappa}B (I{kappa}B) were analyzed by Western blot analysis.

RESULTS. Lutein suppressed the development of EIU in a dose-dependent fashion. The anti-inflammatory effect of 100 mg/kg lutein was as strong as that of 1 mg/kg dexamethasone. Treatment with lutein reduced the concentrations of NO, TNF-{alpha}, IL-6, PGE2, MCP-1, and MIP-2 in aqueous humor. Lutein also suppressed the activation of NF-{kappa}B in the ICB as well as iNOS and COX-2 expression and I{kappa}B degradation in RAW cells.

CONCLUSIONS. These findings indicate that lutein has anti-inflammatory effects on EIU by inhibiting the NF-{kappa}B dependent signaling pathway and the subsequent production of proinflammatory mediators.





This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Izumi-Nagai, N. Nagai, K. Ohgami, S. Satofuka, Y. Ozawa, K. Tsubota, K. Umezawa, S. Ohno, Y. Oike, and S. Ishida
Macular Pigment Lutein Is Antiinflammatory in Preventing Choroidal Neovascularization
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2555 - 2562.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology